315 related articles for article (PubMed ID: 26040478)
21. Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial.
Abdellah MS; Abbas AM; Hegazy AM; El-Nashar IM
Contraception; 2017 Jun; 95(6):538-543. PubMed ID: 28088498
[TBL] [Abstract][Full Text] [Related]
22. Interventions for pain with intrauterine device insertion.
Lopez LM; Bernholc A; Zeng Y; Allen RH; Bartz D; O'Brien PA; Hubacher D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD007373. PubMed ID: 26222246
[TBL] [Abstract][Full Text] [Related]
23. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
[TBL] [Abstract][Full Text] [Related]
24. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices.
Enzlin P; Weyers S; Janssens D; Poppe W; Eelen C; Pazmany E; Elaut E; Amy JJ
J Sex Med; 2012 Apr; 9(4):1065-73. PubMed ID: 21492401
[TBL] [Abstract][Full Text] [Related]
25. Contraceptive sales in the setting of the Zika virus epidemic.
Bahamondes L; Ali M; Monteiro I; Fernandes A
Hum Reprod; 2017 Jan; 32(1):88-93. PubMed ID: 27932442
[TBL] [Abstract][Full Text] [Related]
26. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
[TBL] [Abstract][Full Text] [Related]
27. Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.
De Nadai MN; Poli-Neto OB; Franceschini SA; Yamaguti EMM; Monteiro IMU; Troncon JK; Juliato CRT; Santana LF; Bahamondes L; Vieira CS
Am J Obstet Gynecol; 2020 Mar; 222(3):245.e1-245.e10. PubMed ID: 31541635
[TBL] [Abstract][Full Text] [Related]
28. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial.
Swenson C; Turok DK; Ward K; Jacobson JC; Dermish A
Obstet Gynecol; 2012 Aug; 120(2 Pt 1):341-7. PubMed ID: 22825094
[TBL] [Abstract][Full Text] [Related]
29. Immediate postpartum insertion of intrauterine device for contraception.
Lopez LM; Bernholc A; Hubacher D; Stuart G; Van Vliet HA
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003036. PubMed ID: 26115018
[TBL] [Abstract][Full Text] [Related]
30. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of lidocaine-prilocaine cream and vaginal misoprostol in reducing pain during levonorgestrel intrauterine device insertion in women delivered only by cesarean delivery: A randomized controlled trial.
Hashem AT; Mahmoud M; Aly Islam B; Ibrahem Eid M; Ahmed N; Mohamed Mamdouh A; Elkomy R; Fouad Elgamel A; Hamada AAA; Khalil EM; Ashour ASA; Said Ali A; Taher A; Hasan Hussein A; Elzahaby I; Hafez Mohamed Younes M; Salah E; Mojahed EM; Talaat B; ElHodiby M; Kamal Osman N; Adel Nour D; Khamis Y; Aly Hamed Elsallamy A; Ahmed Gehad M; Kotb MMM; Gad Allah SH
Int J Gynaecol Obstet; 2024 May; 165(2):634-643. PubMed ID: 35212402
[TBL] [Abstract][Full Text] [Related]
32. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
[TBL] [Abstract][Full Text] [Related]
33. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
[TBL] [Abstract][Full Text] [Related]
34. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
Hohmann HL; Reeves MF; Chen BA; Perriera LK; Hayes JL; Creinin MD
Contraception; 2012 Mar; 85(3):240-5. PubMed ID: 22067762
[TBL] [Abstract][Full Text] [Related]
35. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial.
Chor J; Bregand-White J; Golobof A; Harwood B; Cowett A
Contraception; 2012 Jun; 85(6):558-62. PubMed ID: 22176793
[TBL] [Abstract][Full Text] [Related]
36. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
37. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
38. Pain scores at the insertion of the 52 MG levonorgestrel-releasing intrauterine system among nulligravidas and parous women.
Chaves IA; Baêta T; Dolabella GB; Barbosa LR; Almeida NM; Oliveira FR; Oliveira EC; L Silva-Filho A; Rocha ALL
Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):399-403. PubMed ID: 34096433
[TBL] [Abstract][Full Text] [Related]
39. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
[TBL] [Abstract][Full Text] [Related]
40. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
